ADAR1 Capital Management, LLC
CIK 1940272
13F filing for Q2 2026・No. 1,547
- Holdings
- US$2.19B
- Quarter change
- +US$486.51M
- Entries
- 277
- Net bought (estimate)
- +US$190.14M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 43
- Sold out 72
- Cut 64
- Added 96
- Corporate actions 0
- Unchanged 59
Largest holdings
262 stocks worth US$2.11B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| ABIVAX SASPONSORED ADS | Added | 1,804,703 | US$240.49M | 11.39% |
| PTGXPROTAGONIST THERAPEUTICS INCCOM | Cut | 960,863 | US$117.78M | 5.58% |
| ROIVROIVANT SCIENCES LTDSHS | Cut | 3,157,008 | US$111.73M | 5.29% |
| SPYSTATE STR SPDR S&P 500 ETF TTR UNIT | Added | 129,087 | US$96.4M | 4.56% |
| IMMUNOVANT INCCOM | Cut | 2,330,716 | US$89.8M | 4.25% |
| ZAI LAB LTDADR | Added | 3,369,034 | US$64.01M | 3.03% |
| AGIOS PHARMACEUTICALS INCCOM | Added | 1,288,053 | US$47.8M | 2.26% |
| CRINETICS PHARMACEUTICALS INCOM | Added | 1,222,080 | US$45.73M | 2.17% |
| EA SERIES TRUSTALPHA ARCH 1-3 | Unchanged | 337,125 | US$39.47M | 1.87% |
| CYTOKINETICS INCCOM NEW | Cut | 457,907 | US$39.01M | 1.85% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.